Ambit Iberia, a leading Life Sciences consultancy specializing in Pharma & Biotech, Digital Solutions, and Medical Devices, is proud to announce a strategic partnership with The Triality Group, a globally recognized advisory and consulting firm helping Life Sciences organizations implement Artificial Intelligence and digital innovation within highly regulated environments.

As Artificial Intelligence rapidly transforms the Life Sciences industry, organizations must ensure that innovation is implemented responsibly, with robust governance, regulatory compliance, quality systems, and patient safety at its core. Through this partnership, Ambit Iberia strengthens its ability to support pharmaceutical companies, biotechnology organizations, medical device manufacturers, CROs, and technology providers in adopting AI confidently while meeting the industry's evolving regulatory expectations.

 “The partnership strengthens Ambit Iberia's Artificial Intelligence capabilities by combining its expertise in regulated Life Sciences with The Triality Group's internationally recognized leadership in AI governance, digital transformation, and regulatory excellence.” 

A defining strength of The Triality Group is its internationally recognized thought leadership in Artificial Intelligence for regulated Life Sciences. Brandi M. Stockton, a recognized leader within the ISPE Artificial Intelligence Special Interest Group (AI SIG) and part of the AI COP Steering Committee, actively contributes to shaping global best practices for AI adoption, including the development of the ISPE GAMP® AI Guide as visionary and leader and the GAMP® 5 Second Edition. Her involvement reflects The Triality Group's active role in advancing trusted AI governance and regulatory best practices across the Life Sciences industry.

This unique combination of industry leadership and practical implementation experience enables The Triality Group to support organizations not only in adopting Artificial Intelligence technologies, but also in establishing the governance models, validation strategies, quality frameworks, and risk management processes required to build trust and enable sustainable AI implementation in GxP-regulated environments.

By joining forces, Ambit Iberia and The Triality Group will provide a differentiated value proposition for organizations across Spain and Europe. Together, they will help clients accelerate digital transformation and AI adoption while ensuring that innovation is supported by robust governance, data integrity, quality systems, and regulatory confidence.

With more than 20 years of experience, Ambit Iberia has established itself as a trusted consulting partner for Life Sciences organizations, supporting digital transformation initiatives while ensuring compliance with industry regulations and quality standards. Its multidisciplinary team specializes in Pharma & Biotech, Digital Solutions, and Medical Devices, helping clients modernize their operations and successfully implement innovative technologies in highly regulated environments.

 "Artificial Intelligence is becoming one of the most transformative forces in Life Sciences. Through this partnership with The Triality Group, we are strengthening our ability to help organizations implement AI responsibly, combining innovation with the governance, quality, and regulatory confidence required in highly regulated environments. This collaboration marks an important milestone in Ambit Iberia's ambition to become a leading Artificial Intelligence partner for the Life Sciences industry across Spain and Europe.", said Brismark, Managing Partner in Ambit Iberia

The Triality Group complements these capabilities with decades of international experience advising Life Sciences organizations on Artificial Intelligence, digital transformation, quality systems, regulatory affairs, Computer Software Assurance (CSA), Computer System Validation (CSV), data integrity, cybersecurity, IT governance, and organizational change management. Through its global ecosystem of trusted partners, the company delivers proven methodologies and best-practice frameworks that enable organizations to innovate responsibly while maintaining compliance and operational excellence.

Together, Ambit Iberia and The Triality Group will empower Life Sciences organizations to unlock the full potential of Artificial Intelligence by combining strategic advisory, implementation expertise, governance, and regulatory excellence. The partnership reflects a shared commitment to enabling innovation that is not only transformative, but also trusted, compliant, and sustainable.

"Artificial Intelligence can only deliver its full potential when innovation is supported by effective governance, quality, and regulatory confidence. By partnering with Ambit Iberia, we are bringing together complementary expertise that will help Life Sciences organizations implement trusted AI solutions while accelerating digital transformation across regulated environments.", explained Brandi M. Stockton, Founder & CEO The Triality Group  

About Ambit Iberia 

Ambit Iberia is a leading Life Sciences consulting firm with more than 20 years of experience supporting organizations across Pharma & Biotech, Digital Solutions, and Medical Devices. The company helps clients successfully navigate digital transformation while ensuring compliance with industry regulations and quality standards. Through its experienced consultants and commitment to innovation, Ambit Iberia enables Life Sciences organizations to optimize operations, accelerate transformation, and embrace emerging technologies in regulated environments. 

About The Triality Group

The Triality Group is a global Life Sciences advisory and consulting firm dedicated to advancing innovation across Artificial Intelligence, data, digital transformation, quality, and regulatory compliance. Leveraging decades of industry expertise, the company supports pharmaceutical companies, medical device manufacturers, CROs, service providers, and technology suppliers in implementing trusted AI and digital solutions within regulated environments. 

The company's experts contribute to internationally recognized industry guidance, including the ISPE GAMP® AI Guide and GAMP® 5 Second Edition, and actively participate in leadership initiatives within the ISPE Artificial Intelligence Special Interest Group (AI SIG). Through its global ecosystem of trusted partners, The Triality Group helps organizations adopt innovative technologies with confidence while maintaining the highest standards of quality, patient safety, and regulatory compliance.